Tumor Vaccines
The main and significant achievement of modern oncology is the introduction of special biologics and injections into therapeutic practice, which are capable of creating anti-cancer immunity.
Dendritic cell based vaccines are a leading weapon in the fight against cancer. Such a medical technique allows not only to completely recover from cancer, but also to increase the survival rate by several years.
Why do the leading oncologists of the world prefer to use anticancer vaccines, rather than chemotherapy? Can immunotherapy be called a promising cancer treatment?
Vaccination as an effective method of treating oncology
It is a method of activating of patient’s immune system against a tumor. Patient’s immune cells are removed from the blood, multiplied and taught to recognize the tumor antigen, and then injected back.
The injection gave positive results, but it was powerless in treating onco-hematological diseases.
Today, vaccination is one of the stages of anticancer therapy. It can’t replace chemotherapy, but in combination with it improves the clinical effect at times.
Antitumor vaccine is a purely individual concept. It is made from tumor tissues. In other words, after the surgical removal of tumor, a small piece of regenerated tissue is taken and a vaccine is made from it.
This technology allows you to directly receive anti-tumor antigens, related to this type of cancer. Introduced antigens serve as a kind of "killers": they destroy all malignant cells that can remain in the body even after the removal of the tumor. This vaccine can kill cancer, preventing it from metastasing, and the technique can completely replace the course of chemotherapy.
Antitumor vaccines: what is the advantage?
In comparison with chemotherapy and surgery, vaccination with immune cells has many advantages:
- Low level of adverse reactions and effects, as well as the exclusion of complications;
- Improving the quality of human life;
- Increased survival;
- Exclusively individual approach to treatment;
- Painless and no need for hospitalization;
- High clinical efficacy.
Treatment on the basis of dendritic or immune cells allows to achieve stable remission even in cases of metastatic cancer.
Leading oncologists in Europe are actively using vaccines in treatment of cancer of the liver, kidneys, lungs, breast and prostate gland, with metastatic cancer, with brain tumors.
Cellular T-therapy allows not only to reprogramme the T-cells of the patient’s immune system, but also to direct them to the active search and destruction of affected cells.
One of the main advantages of cell therapy is the fact that the tuned cells completely remove the cancer cells, but at the same time do not affect healthy and living cells.
However, vaccination is not given to all patients with cancer. It is the attending physician who determines the way to treat cancer: if in a particular case chemotherapy or radiation therapy allows to achieve greater efficiency, the injection of immune cells is not useful. But if in therapy additional measures are necessary to enhance the clinical effect, then vaccinations take place.
To date, the effectiveness of the anticancer injections is confirmed for cancer with different localization and stages.
